Could a simple drug make shoulder surgery safer and clearer?

NCT ID NCT07686705

Completed Disease control Sponsor: Konkuk University Medical Center Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial investigates whether tranexamic acid, a drug that reduces bleeding, improves visual clarity during arthroscopic rotator cuff repair. Patients with full-thickness rotator cuff tears receive the drug either through an IV or directly into the joint, and surgeons rate how clear the view is during the procedure. The goal is to find the best way to give the drug to make surgery smoother and potentially reduce complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tranexamic acid
What this could lead to: If it works, this could make rotator cuff surgery clearer and safer, potentially reducing complications and improving outcomes.
What could go wrong: This is a small, single-center trial. Tranexamic acid carries risks like allergic reactions or blood clots, and the results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ROTATOR CUFF TEARS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Rotator Cuff Injuries rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ROTATOR CUFF TEARS

Contacts and locations

Show contact details

Locations

Konkuk University Medical Center

Seoul, Seoul, 05030, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.